Contact Us

In the News

Aardvark Therapeutics has been featured in numerous online resources and media sites.

Updates
Publications
Company Presentations

Interview with NYSE: Revolutionizing Obesity Treatment with ARD-101

Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, joined Judy Shaw on #NYSEFloorTalk to talk about their innovative obesity...

READ MORE »

Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, interviews on accomplishments with Nasdaq

Nasdaq Listings Host Kristina Ayanian delves into companies’ notable accomplishments, industry trends, and the driving factors behind their success through...

READ MORE »

Aardvark Therapeutics Announces $85 Million Oversubscribed Series C Financing

Series C financing led by Decheng Capital and supported by a syndicate of new and existing investors including Cormorant Asset...
READ MORE »

Aardvark Therapeutics Announces Receipt of FDA Rare Pediatric Disease Designation for Prader-Willi Syndrome and Expands the Ongoing Phase 2 Clinical Trial

The FDA granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare...
READ MORE »
Load More

Activating Homeostatic Pathways for the Treatment of Disease

Get in Touch to Discover More

Contact Us
Instagram Facebook Linkedin
© 2024 Aardvark Therapeutics, Inc. All Rights Reserved.
Contact Us
Instagram Facebook Linkedin